IP Library Assignment 067486/0847
Patent Assignment
Reel/Frame 067486/0847

Change of Name

Recorded: 2024-05-21 Pages: 4
Assignor
EBRIS PHARMA CO.
Executed: 2024-04-01
Assignee
INTERLUDE BIOPHARMA CO.
1450 BRICKELL AVE., MIAMI, FLORIDA, 33131
Covered Property (1)
Larazotide Formulations
Application: 17/635,441 →
Publication: US 2022/0331392
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 25, 2023
From: MADAN, JAY P.; RADHAKRISHNAN, BALASINGHAM; MUSSO, GARY F.
To: INNOVATE BIOPHARMACEUTICALS, INC.
Reel/Frame 062479/0710 →
Change of Name Jan 25, 2023
From: INNOVATE BIOPHARMACEUTICALS, INC.
To: 9 METERS BIOPHARMA, INC.
Reel/Frame 062492/0981 →
Intellectual Property Security Agreement Apr 10, 2023
From: 9 METERS BIOPHARMA, INC.; NAIA RARE DISEASES, LLC
To: HIGH TRAIL SPECIAL SITUATIONS LLC
Reel/Frame 063281/0653 →
Assignment of Assignor's Interest May 21, 2024
From: 9 METERS BIOPHARMA, INC.
To: EBRIS PHARMA CO.
Reel/Frame 067486/0234 →